Freely Filtered 054: EMPA Kidney!
Freely Filtered, a NephJC Podcast
00:00
Is There a Higher Risk of Serious Hyperkalemia?
There isn't a higher risk of that in our impagliflosing compared to the placebo. There's a lower risk. That's what I meant. So that was good in that. We collected seri investigator reported hyperkalemia events and then also collected serial labs as well. And at least in credence and DAPPA CKD, we found that there was pretty striking concordance between the reduction in risk of investigator reportedhyperkalemia and time to serious potassium greater than six. Just tell me the testing went over six, how many times. Yeah, yeah, that's what it looks like. It looks like it's stopping. Added to the drinking water
Transcript
Play full episode
